VIDRALA SA INH. EO 1,02/ ES0183746314 /
20/05/2024 19:54:59 | Chg. +0.80 | Volume | Bid19:59:30 | Demandez à19:59:30 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
111.00EUR | +0.73% | 0 Chiffrre d'affaires: 0.00 |
-Bid taille: - | -Ask la taille: - | 3.61 Mrd.EUR | 1.13% | 15.49 |
Newsfile Corp
04:49
Tradewave Capital Plc Solidifies Its Position in Financial Markets with Vienna Stock Exchange Listin...
GlobeNewswire
04:38
Stockholder Alert: Robbins LLP Informs Investors that a Class Action Against Teladoc Health, Inc. (T...
Newsfile Corp
04:19
PaleBlueDot Launches $EARTH Token: A Unique Cryptocurrency with a Mission for Global Sustainability
GlobeNewswire
03:00
Volvo Trucks North America and Volvo Financial Services Launch Volvo on Demand to Accelerate Battery...
GlobeNewswire
03:00
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf o...
GlobeNewswire
03:00
GROCERY OUTLET ALERT: Bragar Eagel & Squire, P.C. is Investigating Grocery Outlet Holding Corp. on B...
GlobeNewswire
03:00
VESTIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Again...
GlobeNewswire
02:25
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire
02:15
West Coast Community Bancorp and 1st Capital Bancorp Announce Agreement to Merge
GlobeNewswire
02:00
AST Mining Unveils Free Cloud Mining, Paving the Way for Seamless Crypto Investment in 2024.
GlobeNewswire
02:00
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Be...
GlobeNewswire
01:46
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page